ea0089t8 | Trials In Progress | NANETS2022
Chauhan Aman
, Sue O'Dorisio M.
, Gaze Mark
, Sabado Constantino
, Brouri Fazia
, Xu Lingfei
Background: GEP-NETS and PPGLs in pediatric patients are rare; however, recognition of these diseases has increased recently. 1020% of pediatric patients with GEP-NETs and up to 47% of pediatric patients with PPGLs present with metastatic disease at diagnosis. The disease is often unresectable with poor prognosis, and very few non-surgical therapies are approved for these patients. Due to paucity of data surrounding treatments for pediatric patients with advanced GEP-NET...